{"nctId":"NCT02553473","briefTitle":"Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis","startDateStruct":{"date":"2015-10","type":"ACTUAL"},"conditions":["Neuroborreliosis, Borrelia Burgdorferi"],"count":121,"armGroups":[{"label":"Doxycycline for 6 weeks","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Doxycycline"]},{"label":"Doxycycline for 2 weeks + placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Doxycycline","Drug: Placebo"]}],"interventions":[{"name":"Doxycycline","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Neurological symptoms suggestive of LNB without other obvious reasons and one or both of\n\n   1. Cerebrospinal fluid pleocytosis â‰¥5 leukocytes pr mm3\n   2. Intrathecal Bb antibody production\n2. Signed informed consent\n\nExclusion Criteria:\n\n* Age less than 18 years\n* Pregnancy, breast-feeding\n* Adverse reaction to tetracyclines\n* Treatment with cephalosporin, penicillin, or tetracycline the last 14 days\n* Serious liver or kidney disease that contraindicates use of doxycycline\n* Lactose intolerance\n* Need to use medications contraindicated according to Summary of Product Characteristics of the Investigational Medicinal Product","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Difference in Composite Clinical Score From Inclusion to Six Months After Ended Treatment","description":"Clinical change on composite clinical score (CCS) defined as score at inclusion minus score at 6 months after treatment.CCS consisted of 32 variables,scored from 0 to 2 points.Minimum 0 points,maximum 64 points.High scale score indicated worse outcome.\n\nVariables scored:Malaise,Fatigue,Headache,Neck and/or back pain,Abdominal and/or breast pain,Arm pain,Leg pain,Generalised pain located to joints and/or muscles,Memory and/or concentration problems,Other,Facial palsy,Paresis of the eye muscles,Reduced hearing,Other cranial neuropathies,Cervical radicular sensory findings,Cervical radicular paresis,Thoracic radicular sensory findings,Lumbar radicular sensory findings,Lumbar radicular paresis,Non-radicular sensory findings,Non-radicular paresis,Other,Central findings in one extremity,Central findings in a hemi pattern,Central findings in both legs,Central findings in all extremities,Gait ataxia,Dysphasia/aphasia, Nystagmus,Involuntary movement including tremor,Cognitive impairment,Other.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.4","spread":null},{"groupId":"OG001","value":"6.4","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":61},"commonTop":[]}}}